W. Heinz

E. Anaissie, L. Pagano, M. Nucci, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

A. Barać, J. García-Martínez, D. Seidel, 2019, The Journal of antimicrobial chemotherapy.

Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis

T. Boch, W. Hofmann, P. M. Deckert, 2019, Mycoses.

Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities

C. Heussel, W. Hofmann, H. Wolf, 2013, Journal of Clinical Microbiology.

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.

W. Hofmann, S. Reuter, S. Krause, 2012, The Journal of antimicrobial chemotherapy.

Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples

W. Hofmann, H. Wolf, S. Krause, 2012, European journal of haematology.

Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents

E. Thiel, C. Junghanss, W. Heinz, 2011, Haematologica.

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

J. Panse, T. Südhoff, H. Wolf, 2013, Annals of Hematology.

Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)

M. Hallek, S. Stilgenbauer, K. Kreuzer, 2020, Haematologica.

Forty-one recent cases of invasive zygomycosis from a global clinical registry.

A. Simon, Y. Roth, V. Rickerts, 2009, The Journal of antimicrobial chemotherapy.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

J. Perfect, G. Rahav, F. Marty, 2016, The Lancet. Infectious diseases.

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

H. Waskin, J. Maertens, N. Kartsonis, 2014, Antimicrobial Agents and Chemotherapy.

Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia

M. Ebinger, R. Handgretinger, F. Blaeschke, 2016, Medical mycology.

Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.

B. Schöttker, J. Seufert, F. Weissinger, 2006, Haematologica.

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

G. Rahav, F. Marty, R. Herbrecht, 2019, Medical mycology.

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

G. Rahav, R. Herbrecht, J. Maertens, 2018, Mycoses.

Erratum: Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease [J Antimicrob Chemother, 72, (2017) (3406-3413)] doi: 10.1093/jac/dkx263

H. Waskin, H. Ostermann, J. Maertens, 2017 .

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries

L. Pagano, A. Simon, M. Vehreschild, 2013, Haematologica.

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study

J. Löffler, J. Löffler, H. Horst, 2012, European Journal of Clinical Microbiology and Infectious Diseases.

Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection

M. Vehreschild, A. Langston, S. Huyck, 2012, Antimicrobial Agents and Chemotherapy.

State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)

O. Kurzai, V. Rickerts, A. Groll, 2021, Mycoses.

Pharmacokinetics of chewed vs. swallowed raltegravir in a patient with AIDS and MAI infection: some new conflicting data

R. Schmid, C. Spinner, G. von Figura, 2015, AIDS Research and Therapy.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

A. Thiébaut, U. Flückiger, C. Cordonnier, 2011, Bone Marrow Transplantation.

Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation

R. Handgretinger, F. Blaeschke, P. Lang, 2017, Journal of Cancer Research and Clinical Oncology.

Therapeutic drug monitoring of antifungal agents1)

H. Klinker, W. Heinz, 2012 .

Therapeutisches Drug Monitoring von Antimykotika/Therapeutic drug monitoring of antifungal agents

H. Klinker, W. Heinz, 2012 .

Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice

W. Heinz, A. Böhme, G. Silling, 2011, Current medical research and opinion.

Primary antifungal prophylaxis in leukaemia patients

C. Lass‐Flörl, J. Maertens, O. Cornely, 2007 .

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

C. Lanvers-Kaminsky, G. Hempel, G. Würthwein, 2011, Antimicrobial Agents and Chemotherapy.

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

J. Gerss, C. Lanvers-Kaminsky, A. Groll, 2010, Antimicrobial Agents and Chemotherapy.

P1293 Comparison of plasma trough concentrations of voriconazole in patients with or without comedication of ranitidine or pantoprazole

H. Einsele, S. Scheuermann, H. Klinker, 2007 .

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

X. Schiel, D. Buchheidt, F. Weissinger, 2017, Annals of Hematology.

Original Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

G. Rahav, F. Marty, R. Herbrecht, 2020 .

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul‐Ehrlich‐Society for Chemotherapy

A. Glasmacher, V. Rickerts, E. Presterl, 2011, Mycoses.

Simultaneous Determination of Voriconazole and Posaconazole Concentrations in Human Plasma by High-Performance Liquid Chromatography

H. Klinker, W. Heinz, K. Kahle, 2009, Antimicrobial Agents and Chemotherapy.

CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

S. Hähnel, J. Panse, H. Wolf, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

H. Waskin, H. Ostermann, J. Maertens, 2017, The Journal of antimicrobial chemotherapy.

Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation

H. Einsele, H. Klinker, W. Heinz, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Relevance of Timing for Determination of Posaconazole Plasma Concentrations

H. Klinker, W. Heinz, D. Schirmer, 2011, Antimicrobial Agents and Chemotherapy.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

C. Beigelman-Aubry, L. Pagano, C. Heussel, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation

V. Rickerts, K. Tintelnot, W. Heinz, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

H. Einsele, M. Kiehl, J. Vehreschild, 2016, Annals of Hematology.

Endophthalmitis as primary clinical manifestation of fatal fusariosis in an allogeneic stem cell recipient

H. Einsele, O. Kurzai, W. Heinz, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis

G. Egerer, W. Heinz, J. Greiner, 2013, Mycoses.

Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure

K. Bergmann, L. Klimek, S. Engelhart, 2017, Allergo Journal International.

Combined real‐time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies

H. Einsele, J. Springer, J. Loeffler, 2013, British journal of haematology.

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.

T. Boch, W. Hofmann, S. Krause, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals.

J. Vehreschild, T. Rachow, G. Egerer, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions

G. Mikus, A. Blank, G. Egerer, 2018, Basic & Clinical Pharmacology & Toxicology.

Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples.

H. Einsele, J. Springer, J. Loeffler, 2016, Journal of medical microbiology.

Diagnostic work up to assess early response indicators in invasive pulmonary aspergillosis in adult patients with haematologic malignancies

D. Buchheidt, J. Vehreschild, W. Heinz, 2019, Mycoses.

A Novel Extraction Method Combining Plasma with a Whole-Blood Fraction Shows Excellent Sensitivity and Reproducibility for Patients at High Risk for Invasive Aspergillosis

H. Einsele, J. Springer, J. Loeffler, 2012, Journal of Clinical Microbiology.

Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.

D. Seidel, M. Vehreschild, J. Vehreschild, 2019, The Journal of hospital infection.

Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative

W. Melchers, J. Springer, J. Loeffler, 2015, Journal of Clinical Microbiology.

Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.

H. Einsele, J. Löffler, J. Springer, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Multicenter Comparison of Serum and Whole-Blood Specimens for Detection of Aspergillus DNA in High-Risk Hematological Patients

H. Einsele, J. Springer, J. Loeffler, 2013, Journal of Clinical Microbiology.

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)

N. Bannert, N. Scherbaum, V. Bremer, 2016, BMC Public Health.

PGA4, a GAS homologue from Candida albicans, is up-regulated early in infection processes.

B. Hube, S. Thewes, F. Mühlschlegel, 2007, Fungal genetics and biology : FG & B.

Prevention and treatment of febrile neutropenia

F. Weissinger, W. Heinz, 2012, memo - Magazine of European Medical Oncology.

Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

H. Auner, S. Reuter, H. Wolf, 2012, Annals of Hematology.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

G. Papanicolaou, J. Mehta, J. Panse, 2018, The Lancet.

Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals

A. Glasmacher, P. Brossart, U. Germing, 2014, Infection.

Bendamustine Followed By Obinutuzumab and Idelalisib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BCG Trial of the German CLL Study Group (GCLLSG)

M. Hallek, S. Stilgenbauer, K. Kreuzer, 2020 .

Bendamustine, Followed by Ofatumumab and Ibrutinib in Chronic Lymphocytic Leukaemia (CLL2-BIO): Primary Endpoint Analysis of a Multicentre, Open-Label Phase-II Trial

M. Hallek, S. Stilgenbauer, K. Kreuzer, 2019, SSRN Electronic Journal.

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

C. Charbonneau, J. Maertens, J. Mensa, 2016, ClinicoEconomics and outcomes research : CEOR.

Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia

H. Einsele, W. Heinz, Marie Gründahl, 2020, Mycoses.

HPLC method for the determination of the S- and R-diastereomers of telaprevir for treatment of patients with hepatitis C

H. Klinker, W. Heinz, D. Schirmer, 2015 .

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

C. Schaefer-Prokop, F. Baron, M. Paesmans, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

M. Hoenigl, R. Krause, B. Liss, 2023, The Journal of antimicrobial chemotherapy.

A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease

H. Einsele, J. Springer, J. Loeffler, 2017, Journal of Clinical Microbiology.

Hematological Patients Aspergillus DNA in High-Risk Whole-Blood Specimens for Detection of Multicenter Comparison of Serum and

H. Einsele, J. Springer, P. White, 2014 .

Pathogen-Specific DNA Enrichment Does Not Increase Sensitivity of PCR for Diagnosis of Invasive Aspergillosis in Neutropenic Patients

H. Einsele, O. Kurzai, J. Springer, 2010, Journal of Clinical Microbiology.

[Medical Diagnostics for Mold Exposure Indoors].

L. Klimek, S. Engelhart, G. Wiesmüller, 2016, Pneumologie.

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study

J. Löffler, H. Horst, B. Hertenstein, 2013, European Journal of Clinical Microbiology & Infectious Diseases.